Pfs48/45 malaria vaccine candidate with Matrix-M adjuvant
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Pfs48/45 malaria vaccine candidate with Matrix-M adjuvant, covering 2025-03-28 to 2025-03-28. Get the full timeline:
Most recent: Clinical Trial Update: A Study of the Plasmodium Falciparum Malaria Vaccine Candidate Pfs48/45 in Matrix-M Adjuvant in the UK [EARLY_Phase 1]